Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

647
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
647

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study.

Cancer letters·2026
Same author

CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Intersectional challenges facing women in radiology and oncology.

The British journal of radiology·2026
Same author

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports.

Blood vessels, thrombosis & hemostasis·2026
Same author

From Classical Machine Learning to Emerging Foundation Models: Review on Multimodal Data Integration for Cancer Research.

ArXiv·2025
Same author

Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer.

European radiology·2025
Same journal

Editors' Recognition for Reviewing in 2025.

Journal of thoracic imaging·2026
Same journal

The Diagnostic and Prognostic Value of Multi-Chamber Strain Analysis by Cardiac MRI in Amyloidosis.

Journal of thoracic imaging·2026
Same journal

Computed Tomography-Derived Nakata Index as a Predictor of Functional Impairment in Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.

Journal of thoracic imaging·2026
Same journal

Regarding the Society of Thoracic Radiology Mentoring Program.

Journal of thoracic imaging·2026
Same journal

Pulmonary Fungal Infections in Immunocompetent Patients.

Journal of thoracic imaging·2026
Same journal

The Air-Cleft Sign: Imaging and Histopathologic Findings in 7 Cases of Pulmonary Benign Metastasizing Leiomyomatosis.

Journal of thoracic imaging·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.1K

Targeted Therapy and Imaging Findings.

Girish S Shroff1, Marcelo F Benveniste, Patricia M de Groot

  • 1Departments of *Diagnostic Radiology †Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Journal of Thoracic Imaging
|August 24, 2017
PubMed
Summary
This summary is machine-generated.

Advanced non-small cell lung cancer (NSCLC) treatment is shifting to personalized medicine. Identifying genetic mutations like EGFR and ALK allows for targeted therapies, improving patient outcomes.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Related Experiment Videos

Last Updated: Feb 24, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.1K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Area of Science:

  • Oncology
  • Medical Imaging
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) is often diagnosed at advanced stages, limiting curative surgical or radiation options.
  • Current median survival for advanced NSCLC is approximately 10 months, highlighting the need for improved systemic therapies.
  • Treatment paradigms are evolving towards personalized medicine, driven by the identification of specific genetic biomarkers.

Purpose of the Study:

  • To discuss the imaging characteristics of advanced NSCLC with identified genetic abnormalities.
  • To review the evolution of targeted therapies for NSCLC based on genetic mutations.
  • To describe the imaging manifestations of these targeted therapies.

Main Methods:

  • Review of current literature on NSCLC genetics, targeted therapies, and imaging.
  • Analysis of imaging findings in patients with EGFR and ALK mutations.
  • Correlation of therapeutic interventions with imaging response.

Main Results:

  • Genetic mutations such as EGFR and ALK drive tumor growth in NSCLC.
  • Targeted therapies (e.g., erlotinib, gefitinib, crizotinib) are effective against specific mutations.
  • Antiangiogenesis agents like bevacizumab offer another therapeutic avenue.
  • Distinct imaging patterns are associated with specific genetic profiles and treatment responses.

Conclusions:

  • Personalized treatment strategies based on genetic biomarkers are crucial for advanced NSCLC.
  • Targeted therapies demonstrate efficacy in NSCLC harboring specific mutations.
  • Imaging plays a vital role in characterizing NSCLC, monitoring treatment response, and understanding therapeutic effects.